Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Baudax Bio is a specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 2, 2022 | Post-IPO Equity | $5M | — | — | — | Detail |
Aug 29, 2022 | Post-IPO Equity | $6.20M | — | — | — | Detail |
May 17, 2022 | Post-IPO Equity | $2M | — | — | — | Detail |
Feb 24, 2022 | Post-IPO Equity | $10M | — | — | — | Detail |
Dec 28, 2021 | Post-IPO Equity | $4.20M | — | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Marathon Asset Management | Yes | Post-IPO Debt |